What is liquid-based thin-layer cytology?
Nov 08, 2021
Source: Cainiu Health
Dr. Yan Ying
Introduction
Liquid-based thin-layer cytology, clinically abbreviated as TCT, refers to cytological examination of cervical cells and serves as a screening method for precancerous cervical lesions. The TCT test utilizes a liquid-based thin-layer cytology detection system to analyze cervical cells and provides diagnostic classification according to the internationally accepted Bethesda System (TBS). It is currently the most advanced cytological testing technique worldwide.
Liquid-based thin-layer cytology—commonly known as the ThinPrep Cytologic Test (TCT)—is a screening and diagnostic method for cervical cancer. If abnormalities, particularly cellular lesions, are detected during TCT testing, further evaluation—including colposcopy and human papillomavirus (HPV) testing—is required to confirm or rule out cervical cancer. Below, we explain what liquid-based thin-layer cytology entails.
What Is Liquid-Based Thin-Layer Cytology?
Clinically abbreviated as TCT, liquid-based thin-layer cytology is a cytological examination of cervical cells and serves as a primary screening tool for precancerous cervical lesions. The TCT utilizes a liquid-based thin-layer cytology detection system to collect and process cervical cells, followed by classification and diagnosis according to the internationally standardized Bethesda System (TBS). Currently, TCT represents the most advanced cytological testing technology worldwide. Compared with conventional Papanicolaou (Pap) smear tests, TCT significantly improves specimen adequacy and enhances the detection rate of abnormal cervical cells. Its sensitivity for detecting cervical cancer cells approaches 100%. Moreover, TCT can also identify precancerous lesions and detect various microorganisms—including fungi, trichomonads, and Chlamydia. Today, TCT has been widely adopted for cervical cancer screening in women across major cities in Europe, North America, and China.
Knowledge Extension: Key Considerations for Liquid-Based Thin-Layer Cytology
To ensure optimal test accuracy, patients should abstain from sexual intercourse for three days prior to the test, avoid vaginal medications, and schedule the examination outside of menstruation. When performed during the non-menstrual phase, TCT achieves nearly 100% detection sensitivity for cervical cancer cells and can identify atypical squamous cells, low-grade squamous intraepithelial lesions (LSIL), atypical endocervical cells, atypical endometrial cells, and atypical glandular cells—as well as certain precancerous conditions.
Additionally, this test helps determine whether the patient is infected with fungi or trichomonads and may indicate bacterial vaginosis. As an integral component of cervical cancer screening, TCT complements HPV testing: if high-risk HPV infection is confirmed and TCT results are abnormal, colposcopy and/or histopathological examination and diagnosis are indicated. Maintaining strong health awareness and undergoing regular cervical cancer screening are essential preventive measures.
The above provides a comprehensive overview of liquid-based thin-layer cytology. We hope this information proves helpful. Wishing you a joyful life and robust health!
